🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.03 mL Serving Size
360 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

22.5 mcg
✅ Within RDA (0.2× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.0225mg

Other Ingredients

Medium Chain Triglyceride Oil D-Alpha-Tocopherol Rosemary extract

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Children 4 or More Years of Age Vegetarian Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: Children 4 years of age or older: take one drop daily or as directed by your healthcare professional. May be put in food or a drink.

⚠️ Warnings & Precautions

Warning: Vitamin K can antagonize the effect of anticoagulants, including warfarin. Do not take this product if you are taking Warfarin or are pregnant or breastfeeding without first consulting with your physician.

Keep out of the reach of children.

Do not use if security seal is broken or missing.

🧪 Formulation Notes

IGEN Non-GMO tested

An FDA Regulated Facility

Gluten-free No artificial preservatives Soy-free

Vitamin K2 MK-7 is one of the most important nutrients for developing healthy bones and helping to maintain their strength long-term. Kid's Super Daily K2, derived from chickpeas, provides the most bioactive form of vitamin K2 in a single, concentrated drop.

Liquid vitamin K

Non-GMO

Supports and promotes: Bone health Healthy blood Calcium assimilation Cardiovascular support Healthy development

Additional Information

IGEN Non-GMO tested

Store bottle upright at room temperature.

Please recycle

1033-3a

Product Details

UPC / SKU 0 88395 10330 8
DSLD Entry Date 2024-05-23
Product Type Vitamin
Form Liquid
Brand Carlson
DSLD ID 309238
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →